Browsing Tag
orthopedic biotech
1 post
Bone Biologics prices $5m equity and warrant offering to accelerate spinal fusion trial development
Bone Biologics Corporation has priced a $5 million public offering to advance its spine fusion therapy trials and intellectual property. Learn what this means for investors.